PubMed Health⌕ Search

Biomedical subjects

E Sternieri

Publications and source records attributed to E Sternieri.

At least 37 records · Page 2Linked to original sources
PubMed1986

Effectiveness of flunarizine in altering electronystagmographic patterns in migraine patients: a preliminary report.

In this double-blind study versus placebo, the anti-migraine efficacy of flunarizine 20 mg/per os/day for 14 days, followed by 10 mg/per os/day up to 120 days has been evaluated in 30 patients suffering from common and classical migraine. During the trial the vestibular function (slow phase velocity (SPV) and number of spikes) was also studied. To date 18 patients have completed the study. The results show a significant difference before and after the treatment with flunarizine, while no difference was observed in the placebo group, with regard to headache unit indices. Flunarizine seems to increase SPV max, which is reduced between attacks in migraine patients; the number of spikes does not change significantly.

Adolescent↗
PubMed1985

Influence of flunarizine on the altered electronystagmographic (ENG) recordings in migraine.

Flunarizine, a slow-channel calcium blocker, appeared to be effective in the prophylactic treatment of common and classic migraine in 29 out-patients included in a double-blind clinical trial. After a two-month placebo period, half the patients were treated with flunarizine, 10 mg a day for up to 120 days, half with placebo. Electronystagmographic (ENG) recordings were performed at the end of the common placebo period and after two and four months of treatment, respectively. There was a significant reduction in Headache Unit Index (HUI) and Headache Unit Index Corrected (HUIC) (42% and 40.5% respectively) in the flunarizine-treated group but not in the placebo group. Analgesic intake was reduced and intensity of pain was unchanged in both groups throughout the trial. ENG data were not significantly affected by flunarizine treatment.

Adult↗
PubMed1984

Dizziness and headache.

Dizziness and headache have been known to be associated in both adults and children, since early this century. Otoneurological examination of headache sufferers at the University of Modena Headache Centre revealed a high percentage of ENG alterations indicating a mainly bulbo-pontine vestibular disorder. The lesion, which is more significant on the side more affected, is modified during attacks and with time. The authors suggest that in these patients migraine and dizziness have a common pathogenesis in alterations of neuromediators and/or their receptors and that ENG may be useful in evaluating headache.

Dizziness↗
PubMed1983

Circadian variations of proopiocortin-related peptides in children with migraine.

Basal and throughout-the-day variations of B-lipotropin (BLPH), B-endorphin (BEP), ACTH and cortisol plasma levels were studied in seven prepubertal children who had been affected by common migraine for periods of 6-26 months and in six healthy volunteers. Despite normal cortisol concentrations, children with migraine show higher BLPH (15.1 +/- 2.7 fmol/ml, M +/- SE), ACTH (25 +/- 2.7) and BEP (9.1 +/- 1.1) levels than controls. In both groups of children, evening values (8 p.m.) were significantly lower than morning values, but in migraineurs the decrease of the three peptides was less. The raised proopiocortin-related peptide plasma levels found in children suffering from migraine cannot be explained at present, although the discomfort experienced by the patients may create a situation of chronic stress which could explain such a finding. Whatever the explanation is, these findings differentiate prepubertal migraine from the most severe forms of headache occurring in adult life where lower than normal opioid levels have been demonstrated.

Adrenocorticotropic Hormone↗
PubMed1983

The renin-aldosterone system and electrolyte balance during tocolytic therapy.

The effects of short and long-term tocolytic therapy, with salbutamol on renin activity, aldosterone levels, sodium and potassium concentration in urine, blood, and red blood cells in 44 pregnant women were studied. No significant changes were observed in renin activity and aldosterone levels between the 1st and 5th days of i.v. or p.o. therapy and in 24-h sodium urinary excretion. Serum potassium levels significantly decreased by the 2nd and 4th h from start of i.v. infusion of salbutamol, returning to preinfusion levels within 24-36 h, whereas no concomitant increase in red cell potassium levels was detected. Urinary potassium excretion showed significant decrease within 24 h from start of i.v. therapy, returning to control levels after 48 h. No change in sodium concentration in blood and red blood cells was observed.

Administration, Oral↗
PubMed1983

Drug addiction during pregnancy.

On the basis of current literature and their own experience, the authors discuss (1) the major complications possible in pregnant drug addicts, (2) whether the complications can be attributed to deficient prenatal care or to effects of drug abuse, and (3) the best prenatal care of drug-addicted mothers.

Birth Weight↗